The Motley Fool. DATE Monday, July 14, 2025 at 5 p.m. EDT CALL PARTICIPANTS Chief Executive Officer -- Shawn O'ConnorChief ...

Fintel reports that on July 15, 2025, Keybanc downgraded their outlook for Simulations Plus (NasdaqGS:SLP) from Overweight to ...

Shares of Simulations Plus, Inc SLP -9.85% Get Free Report fell sharply in pre-market trading after the company reported ...

Simulations Plus Inc. reported lower than expected sales and reduced guidance due to cautious biopharma spending.

CFO William Frederick stated, "To recap our third quarter performance, total revenue increased 10% to $20.4 million, including a $2.4 million contribution from the Pro-ficiency acquisition. Software ...

RESEARCH TRIANGLE PARK, N.C. (AP) — RESEARCH TRIANGLE PARK, N.C. (AP) — Simulations Plus Inc. (SLP) on Monday reported a loss of $67.3 million in its fiscal third quarter.

Simulations Plus, Inc. (Nasdaq: SLP) ("Simulations Plus"), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications ...

Investing.com -- Simulations Plus , Inc. (NASDAQ: SLP ), a provider of biosimulation solutions for the biopharma industry, saw its shares surge up to 3.3% after reporting third quarter fiscal 2025 ...

Simulations Plus is reaffirming the preliminary revenue for its third fiscal quarter and full year 2025 revenue guidance which was previously provided on June 11, 2025.

JMP Securities maintained its Market Perform rating on Simulations Plus (NASDAQ:SLP) on Wednesday. The firm significantly reduced its financial forecasts for the pharmaceutical software company ...

Simulations Plus, Inc., a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today ...

Review the current valuation for Simulations Plus Inc (SLP:XNAS) stock based on a yearly calendar providing PE ratios, cash flow, EBITDA and other company valuation information.